Clinical Trials Directory

Trials / Completed

CompletedNCT02742441

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
409 (actual)
Sponsor
Therapeutics, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This Phase 3 study (Study 310) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.

Conditions

Interventions

TypeNameDescription
DRUG122-0551 FoamTopical Foam containing active drug
DRUGVehicle FoamTopical Foam containing no active drug

Timeline

Start date
2016-06-01
Primary completion
2017-02-27
Completion
2017-06-16
First posted
2016-04-19
Last updated
2018-11-14
Results posted
2018-11-14

Locations

21 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02742441. Inclusion in this directory is not an endorsement.

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) (NCT02742441) · Clinical Trials Directory